Writer questions Anthropic IPO amid slowing revenue

garymarcus.substack.com1 min read

The author argues that Anthropic's upcoming IPO is a poor bet for investors and society, suggesting that the company's revenue growth has leveled off and that its broader promises regarding medicine are unrealistic. The piece contends that falling off the exponential revenue trajectory makes a gargantuan sustainable business unlikely as competition increases. Open article →